Cost–Benefit Evaluation of Interferon and Ribavirin for the Treatment of Hepatitis C in District Dera Ismail Khan, Pakistan. (2026). Physical Education, Health and Social Sciences, 4(1), 129-136. https://doi.org/10.63163/jpehss.v4i1.1040